RSS

dementia

The Aztec Group, an independent fund and corporate services provider, has assisted the Dementia Discovery Fund (DDF) with its final close and will continue to support the fund during its administration. more

News

According to a new study from the University of Eastern Finland and the German Center for Neurodegenerative Diseases, DZNE, antiepileptic drugs are associated with an increased risk of Alzheimer’s disease and dementia. more

News

Results from a new register-based study have suggested that blood-thinning drugs not only reduce the risk of stroke in patients with atrial fibrillation (AF) but also significantly reduces the risk of dementia in these patients. more

News

The UK Dementia Research Institute (UK DRI) has taken a huge leap forward with six of the UK leading research universities recently being awarded with centre status. more

News

Professor Giovanna Mallucci and her team have identified two drugs that can block the death of brain cells in mice models of neurodegeneration. This research builds on the earlier breakthrough by the team four years ago. more

News

An important development in the examination of blood vessels in the brain has been made by researchers from the University of Surrey and the Federal University of Sao Paulo. more

News

Global healthcare company Lilly has announced the results of a phase 3 clinical trial, designed to test the efficacy of a drug to slow the effects of Alzheimer’s. more

News

University College London (UCL) research shows that withdrawing donepezil from people with advanced stages of Alzheimer’s doubled their risk of being placed in a nursing home within a year more

News

Following hot on the heels of yesterday’s announcement that Eli-Lilly’s drug solanezumab heralded a breakthrough in the treatment of Alzheimer’s, the EPM team has done some digging and presents four additional newsworthy developments in the field. more

News